CNR2 and glioblastoma: Notably, S1P5 has been reported to exert a negative regulation of the tumorigenic effect induced by CB2 in glioblastoma cells: bioluminescence resonance energy transfer analysis highlighted that this S1P receptor subtype strongly and specifically interacts with CB2 [61].